Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q1112374> ?p ?o }
Showing triples 1 to 23 of
23
with 100 triples per page.
- Q1112374 subject Q6809004.
- Q1112374 subject Q8431759.
- Q1112374 abstract "Lexatumumab (also known as ETR2-ST01) is an experimental agonistic human monoclonal antibody against TRAIL-R2 (DR5, APO-2) undergoing clinical trials for the treatment of cancer.HGS-ETR2 antibodies were generated by HGS through a collaboration with Cambridge Antibody Technology.".
- Q1112374 atcPrefix "none".
- Q1112374 casNumber "845816-02-6".
- Q1112374 fdaUniiCode "967Q0SJD77".
- Q1112374 wikiPageWikiLink Q12078.
- Q1112374 wikiPageWikiLink Q18033388.
- Q1112374 wikiPageWikiLink Q422248.
- Q1112374 wikiPageWikiLink Q5.
- Q1112374 wikiPageWikiLink Q5025351.
- Q1112374 wikiPageWikiLink Q6809004.
- Q1112374 wikiPageWikiLink Q8431759.
- Q1112374 atcPrefix "none".
- Q1112374 casNumber "845816".
- Q1112374 unii "967".
- Q1112374 type ChemicalSubstance.
- Q1112374 type Drug.
- Q1112374 type ChemicalObject.
- Q1112374 type Thing.
- Q1112374 type Q8386.
- Q1112374 comment "Lexatumumab (also known as ETR2-ST01) is an experimental agonistic human monoclonal antibody against TRAIL-R2 (DR5, APO-2) undergoing clinical trials for the treatment of cancer.HGS-ETR2 antibodies were generated by HGS through a collaboration with Cambridge Antibody Technology.".
- Q1112374 label "Lexatumumab".